Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Catalyst Pharmaceuticals (CPRX) over the last 15 years, with Dec 2024 value amounting to $556,000.

  • Catalyst Pharmaceuticals' Capital Expenditures rose 160.00% to $26,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $383,000, marking a year-over-year increase of 4.64%. This contributed to the annual value of $556,000 for FY2024, which is 140.69% up from last year.
  • Catalyst Pharmaceuticals' Capital Expenditures amounted to $556,000 in FY2024, which was up 140.69% from $231,000 recorded in FY2023.
  • In the past 5 years, Catalyst Pharmaceuticals' Capital Expenditures ranged from a high of $1.0 million in FY2021 and a low of $11,000 during FY2020.
  • Its 3-year average for Capital Expenditures is $272,000, with a median of $231,000 in 2023.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 9,181.82% in 2021, then crashed by 97.16% in 2022.
  • Over the past 5 years, Catalyst Pharmaceuticals' Capital Expenditures (Yearly) stood at $11,000 in 2020, then skyrocketed by 9,181.82% to $1.0 million in 2021, then slumped by 97.16% to $29,000 in 2022, then spiked by 696.55% to $231,000 in 2023, then surged by 140.69% to $556,000 in 2024.